ProMIS Neurosciences Institutionelles Eigentum
Was ist das Institutionelles Eigentum von ProMIS Neurosciences?
Institutionelles Eigentum von ProMIS Neurosciences, Inc. ist 0.02%
Was ist die Definition von Institutionelles Eigentum?
Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutionelles Eigentum von Unternehmen in Health Care Sektor auf OTC im Vergleich zu ProMIS Neurosciences
Was macht ProMIS Neurosciences?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Unternehmen mit institutionelles eigentum ähnlich ProMIS Neurosciences
- Mastermyne hat Institutionelles Eigentum von 0.02%
- Sonova AG hat Institutionelles Eigentum von 0.02%
- Standard Chartered PLC hat Institutionelles Eigentum von 0.02%
- CCL Industries hat Institutionelles Eigentum von 0.02%
- MTN hat Institutionelles Eigentum von 0.02%
- Shanghai Gench Education hat Institutionelles Eigentum von 0.02%
- ProMIS Neurosciences hat Institutionelles Eigentum von 0.02%
- Aleafia Health Inc hat Institutionelles Eigentum von 0.02%
- Wm Morrison Supermarkets Plc hat Institutionelles Eigentum von 0.02%
- KAZ Minerals Plc hat Institutionelles Eigentum von 0.02%
- Housing Development and Infrastructure hat Institutionelles Eigentum von 0.02%
- Cnova N.V hat Institutionelles Eigentum von 0.02%
- Orbite Technologies hat Institutionelles Eigentum von 0.02%